vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and WATTS WATER TECHNOLOGIES INC (WTS). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $625.1M, roughly 1.5× WATTS WATER TECHNOLOGIES INC). WATTS WATER TECHNOLOGIES INC runs the higher net margin — 13.4% vs 0.7%, a 12.7% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 15.7%). WATTS WATER TECHNOLOGIES INC produced more free cash flow last quarter ($140.3M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 4.6%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
AERCO International, Inc. is a manufacturer and supplier of commercial condensing boilers, high efficiency water heating equipment and energy recovery systems in the HVAC/plumbing industry across a variety of markets including education, lodging, government, office buildings, healthcare, industrial and multifamily housing. In 1949, AERCO introduced the industry's first semi-instantaneous, tankless steam-to-water water heater. In 1988, AERCO introduced the first condensing and fully modulating...
ASTH vs WTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $625.1M |
| Net Profit | $6.6M | $83.7M |
| Gross Margin | — | 49.5% |
| Operating Margin | 1.9% | 18.2% |
| Net Margin | 0.7% | 13.4% |
| Revenue YoY | 42.9% | 15.7% |
| Net Profit YoY | 184.4% | 24.0% |
| EPS (diluted) | $0.12 | $2.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $625.1M | ||
| Q3 25 | $956.0M | $611.7M | ||
| Q2 25 | $654.8M | $643.7M | ||
| Q1 25 | $620.4M | $558.0M | ||
| Q4 24 | $665.2M | $540.4M | ||
| Q3 24 | $478.7M | $543.6M | ||
| Q2 24 | $486.3M | $597.3M | ||
| Q1 24 | $404.4M | $570.9M |
| Q4 25 | $6.6M | $83.7M | ||
| Q3 25 | $373.0K | $82.2M | ||
| Q2 25 | $9.4M | $100.9M | ||
| Q1 25 | $6.7M | $74.0M | ||
| Q4 24 | $-7.8M | $67.5M | ||
| Q3 24 | $16.1M | $69.1M | ||
| Q2 24 | $19.2M | $82.0M | ||
| Q1 24 | $14.8M | $72.6M |
| Q4 25 | — | 49.5% | ||
| Q3 25 | — | 48.8% | ||
| Q2 25 | — | 50.6% | ||
| Q1 25 | — | 48.8% | ||
| Q4 24 | — | 46.7% | ||
| Q3 24 | — | 47.3% | ||
| Q2 24 | — | 47.7% | ||
| Q1 24 | — | 46.9% |
| Q4 25 | 1.9% | 18.2% | ||
| Q3 25 | 2.0% | 18.2% | ||
| Q2 25 | 3.1% | 21.0% | ||
| Q1 25 | 3.3% | 15.7% | ||
| Q4 24 | 0.1% | 16.5% | ||
| Q3 24 | 5.9% | 17.1% | ||
| Q2 24 | 6.2% | 18.7% | ||
| Q1 24 | 7.5% | 16.9% |
| Q4 25 | 0.7% | 13.4% | ||
| Q3 25 | 0.0% | 13.4% | ||
| Q2 25 | 1.4% | 15.7% | ||
| Q1 25 | 1.1% | 13.3% | ||
| Q4 24 | -1.2% | 12.5% | ||
| Q3 24 | 3.4% | 12.7% | ||
| Q2 24 | 3.9% | 13.7% | ||
| Q1 24 | 3.7% | 12.7% |
| Q4 25 | $0.12 | $2.50 | ||
| Q3 25 | $0.01 | $2.45 | ||
| Q2 25 | $0.19 | $3.01 | ||
| Q1 25 | $0.14 | $2.21 | ||
| Q4 24 | $-0.14 | $2.02 | ||
| Q3 24 | $0.33 | $2.06 | ||
| Q2 24 | $0.40 | $2.44 | ||
| Q1 24 | $0.31 | $2.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $405.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $2.0B |
| Total Assets | $2.2B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $405.5M | ||
| Q3 25 | $463.4M | $457.7M | ||
| Q2 25 | $342.1M | $369.3M | ||
| Q1 25 | $260.9M | $336.8M | ||
| Q4 24 | $290.8M | $386.9M | ||
| Q3 24 | $350.3M | $303.9M | ||
| Q2 24 | $327.7M | $279.4M | ||
| Q1 24 | $337.3M | $237.1M |
| Q4 25 | $779.3M | $2.0B | ||
| Q3 25 | $775.5M | $2.0B | ||
| Q2 25 | $765.5M | $1.9B | ||
| Q1 25 | $745.4M | $1.8B | ||
| Q4 24 | $712.7M | $1.7B | ||
| Q3 24 | $704.6M | $1.7B | ||
| Q2 24 | $678.9M | $1.6B | ||
| Q1 24 | $653.5M | $1.6B |
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.2B | $2.7B | ||
| Q2 25 | $1.4B | $2.6B | ||
| Q1 25 | $1.3B | $2.5B | ||
| Q4 24 | $1.4B | $2.4B | ||
| Q3 24 | $1.3B | $2.4B | ||
| Q2 24 | $1.3B | $2.4B | ||
| Q1 24 | $1.2B | $2.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $154.7M |
| Free Cash FlowOCF − Capex | $-6.0M | $140.3M |
| FCF MarginFCF / Revenue | -0.6% | 22.4% |
| Capex IntensityCapex / Revenue | 0.3% | 2.3% |
| Cash ConversionOCF / Net Profit | -0.44× | 1.85× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $356.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $154.7M | ||
| Q3 25 | $10.0M | $122.4M | ||
| Q2 25 | $90.9M | $69.7M | ||
| Q1 25 | $16.6M | $55.2M | ||
| Q4 24 | $-10.9M | $139.5M | ||
| Q3 24 | $34.0M | $90.7M | ||
| Q2 24 | $23.2M | $85.3M | ||
| Q1 24 | $6.0M | $45.6M |
| Q4 25 | $-6.0M | $140.3M | ||
| Q3 25 | $7.4M | $110.9M | ||
| Q2 25 | $89.5M | $59.5M | ||
| Q1 25 | $13.6M | $45.6M | ||
| Q4 24 | $-13.5M | $127.5M | ||
| Q3 24 | $31.7M | $84.3M | ||
| Q2 24 | $20.4M | $78.5M | ||
| Q1 24 | $5.6M | $35.5M |
| Q4 25 | -0.6% | 22.4% | ||
| Q3 25 | 0.8% | 18.1% | ||
| Q2 25 | 13.7% | 9.2% | ||
| Q1 25 | 2.2% | 8.2% | ||
| Q4 24 | -2.0% | 23.6% | ||
| Q3 24 | 6.6% | 15.5% | ||
| Q2 24 | 4.2% | 13.1% | ||
| Q1 24 | 1.4% | 6.2% |
| Q4 25 | 0.3% | 2.3% | ||
| Q3 25 | 0.3% | 1.9% | ||
| Q2 25 | 0.2% | 1.6% | ||
| Q1 25 | 0.5% | 1.7% | ||
| Q4 24 | 0.4% | 2.2% | ||
| Q3 24 | 0.5% | 1.2% | ||
| Q2 24 | 0.6% | 1.1% | ||
| Q1 24 | 0.1% | 1.8% |
| Q4 25 | -0.44× | 1.85× | ||
| Q3 25 | 26.69× | 1.49× | ||
| Q2 25 | 9.65× | 0.69× | ||
| Q1 25 | 2.48× | 0.75× | ||
| Q4 24 | — | 2.07× | ||
| Q3 24 | 2.11× | 1.31× | ||
| Q2 24 | 1.21× | 1.04× | ||
| Q1 24 | 0.40× | 0.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
WTS
Segment breakdown not available.
